Check out the complete programme of the #IPCS26! apccc.org/ipcs/ Register now for #IPCS26 and #APCCC26 and take advantage of a 20% discount when registering for both events! Events Details: 📍 28-29 April 2026, Palazzo Congressi, Lugano, Switzerland 🎟️ Register here: onlineevent.ch/APCCC/2026

⏳ Early registration for the International Prostate Cancer Symposium (IPCS26 @ipcsymposium.bsky.social ) is closing soon — final deadline: February 28. 👉 Secure your spot before February 28: apccc.org/apccc-2026/r...

ICML has a fresh new branding and website — check it out!

#IORmoments Last week, we were delighted to welcome Prof. Margot Thome to the IOR Lecture Series for her lecture: “Insights into antigen receptor signaling: how the protease MALT1 controls lymphocyte activation and lymphomagenesis.” We thank Prof. Thome for a stimulating presentation!

#IORmoments On Friday, we hosted Prof. Vincenzo Bronte (University of Verona) as part of the IOR PhD Program for his lecture “Evolution of the immune contexture and myeloid cell dynamics in pancreatic cancer immune evasion.” Thank you, Prof. Bronte, for your insightful and inspiring discussion.

The Bellinzona Institutes of Science (Bios+), IOR and IRB, wish you happy Holidays and a happy 2026!

#IORmoments On December 19, 2025, HC Ambrì-Piotta played a solidarity match at the Gottardo Arena in support of La Corsa della Speranza. The team wore a special event jersey, later auctioned to support cancer research in Ticino. 👕 Some jerseys are still available until December 29: hcap.ch/it/asta

#IORnews Major awards to IOR and IOSI at SOHC 2025 in Basel. Congratulations to Prof. Franco Cavalli, Prof. Davide Rossi, Prof. Anastasios Stathis, and Dr. Ghilardi for their well-deserved recognitions. Read more: ior.usi.ch/events-news/...

#IORnews 🎉 Congratulations to Dr. Lisa Pavinato, Postdoctoral Fellow in the Stem Cells and Cancer Lab led by Prof. Arianna Baggiolini on receiving the prestigious Brain & Behavior Research Foundation Young Investigator Grant! 🔗https://shorturl.at/BnMjx

⏳ One month left to submit your abstracts for the International Prostate Cancer Symposium 2026! Don’t miss the December 12, 2025 deadline to submit your work for IPCS 2026. This is a great opportunity to showcase your research to leading experts shaping the future of prostate cancer care ⬇️

#IORnews On the occasion of the 75th anniversary of Switzerland’s recognition of the People’s Republic of China, IOR and IOSI will represent Swiss scientific excellence at a high-level event in Beijing dedicated to oncology research collaboration. Read more: ior.usi.ch/events-news/...

IOR&IOSI for #Movember Many of our researchers dedicate their work to understanding & treating #prostatecancer. This effort is strengthened by our long-standing partnership with IOSI, which has led to exciting discoveries from the lab to the clinic. Don’t forget to get checked - prevention matters.

#IORnews 🎉 Congratulations to Dr. Jonas Van Lent on receiving the prestigious AFM-Téléthon Trampoline Grant! This highly competitive grant supports promising early-career scientists developing bold and innovative projects in rare diseases. 🔗 shorturl.at/ghhNJ

#IORnews 🌊 Researchers from the IOR and the University of Galway in Ireland have identified a new natural compound from Irish marine life showing strong potential against an aggressive, hard-to-treat form of blood cancer. Learn more: ior.usi.ch/events-news/...

#IORmoments Today we were delighted to host Prof. Dr. Zoran Culig from the Medical University of Innsbruck for his lecture on “Androgen receptor coactivators in advanced prostate cancer” in our PhD Lecture Series. Thank you for such an inspiring talk!

#IORnews Congratulations to Prof. Davide Rossi, Group Leader at IOR and Deputy Head of Hematology at IOSI, on his appointment as Full Professor at USI within the Faculty of Biomedical Sciences. 🔗 ior.usi.ch/events-news/...

#IORnews IOR and IRB researchers (Theurillat & Cavalli labs) identify first-in-class inhibitors of FOXA1/FOXA2, long deemed “undruggable” drivers of prostate cancer. ➡️ Learn more: ior.usi.ch/events-news/...

#IORnews An international study conducted by the IOR Experimental Hematology Laboratory, led by Prof. Davide Rossi, offers a new perspective on the genetics of classical Hodgkin lymphoma. Learn more: ior.usi.ch/events-news/...

#PinkOctober 🎀 October is Breast Cancer Awareness Month At IOR, we stand at the forefront of the fight against breast cancer. Our Cancer Immunotherapy Lab studies how cancer cells interact with bacteria and the immune system to develop new therapies. Let’s raise awareness - prevention saves lives.

We had the honor to host Dr. Taewan Kim (DIGIT, South Korea) for a special seminar at IOR. He is renowned for pioneering Parkinson’s disease modeling using human pluripotent stem cells. Thank you for the inspiring talk!

#IORjobs Open positions in the Stem Cells and Cancer Lab, directed by Arianna Baggiolini: - PhD Student: ior.usi.ch/events-news/... - Lab Technician: ior.usi.ch/events-news/... Apply now and join Baggiolini’s international and inspiring team!

#IORmoments Many thanks to Prof. Markus Gerhard for today’s lecture in our PhD Lectures Serie! We truly appreciated his time and the stimulating discussion with our community.

#IORnews IOR study led by Prof. Catapano uncovers key mechanisms driving prostate cancer stem cells and paves the way for innovative therapies. 🔗Learn more: ior.usi.ch/events-news/...

🌐 The IOR Foundation has a brand-new website! Discover more about our Foundation, which manages: - our Institute, the IOR - The International Extranodal Lymphoma Study Group (IELSG) - The International Conference on Malignant Lymphoma (ICML) 🔗 www.foundationior.ch

#IORnews The Lab of Prof. J.P. Theurillat together with Dr. M. Bolis created the Prostate Cancer Atlas, a web-based platform that empowers the research community to explore, compare, and analyze data with unprecedented ease and flexibility. 🔗 short-url.org/1ecu9 www.youtube.com/watch?v=qTjJ...

#IORnews A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL. Learn more: tinyurl.com/ytybcbr8

#IORnews The Cancer Immunotherapy lab, led by Prof. A. Calcinotto, uncover a new immune–tumor interaction in ER+ breast cancer, opening the way for targeted therapies. 🔗Read more: ior.usi.ch/events-news/... @calcinottolab.bsky.social

#IORnews Dr. Perez joins the IOR with a prestigious international grant on drug repurposing for healthy aging, now supported by the SNSF through the Money Follows Researcher agreement. Read more: shorturl.at/pLKnm

#IORnews Among the 32 projects selected for funding in the first half of 2025 by the Swiss Cancer Research Foundation, are 3 research projects from the IOR, led by Prof. A. Alimonti, Prof. F. Bertoni and Prof. D. Rossi, focusing on lymphoma and prostate cancer. Read more: shorturl.at/xqmAd

Registration is open for the International Prostate Cancer Symposium (IPCS) 28–29 April 2026 – Lugano, Switzerland Held just before APCCC 2026, IPCS is your chance to explore next-gen treatments & breakthrough research in prostate cancer care. 🔗Register now: apccc.org

#IORjobs IOR invites applications from outstanding candidates interested in applying for the SNSF Ambizione and Marie Skłodowska-Curie Actions (MSCA) and EMBO fellowships. ⏳ IOR internal deadline: 3 August 2025 ➡️ Details & application procedure: shorturl.at/caVdu

#IORnews New study from Prof. Jean-Philippe Theurillat’s Lab maps proteomic changes in prostate cancer progression, revealing overlooked drivers of aggressiveness. 🔗 Read the news: shorturl.at/wZWou

The annual meeting of the Bellinzona Institutes of Science (Bios+) association, composed of the IOR and the Institute for Research in Biomedicine, took place on 4 June in Bellinzona. During the meeting, atty. G. Gendotti was appointed as the new Bios+ President. biosplus.ch/news-press/2...

The Foundation for the IOR is deeply saddened by the sudden passing of Prof. Esteban Cvitkovic on June 20, 2025. A passionate supporter of our Institute and, until recently, a highly active member of our Scientific Advisory Board, he played a key role in shaping our research. 🔗 shorturl.at/QSUKp

#IORnews The 18th edition of the International Conference on Malignant Lymphoma (18-ICML), one of the most prestigious global events dedicated to lymphoid malignancies, concludes today after a week of intense scientific exchange and groundbreaking presentations. 🔗 ior.usi.ch/events-news/...

#IORnews 🏆 Prof. F. Cavalli, President of the IOR Foundation, has been selected as the 2025 inductee in the Lymphoma category by the Giants of Cancer Care program, a prestigious recognition that honors the world’s most distinguished cancer researchers and clinicians. ➡️ Read more: shorturl.at/j7dbB

#IORnews A Swiss study led by Prof. Davide Rossi opens the door to a new opportunity for patients with relapsed chronic lymphocytic leukemia. 📄 Read more: shorturl.at/bokQS

𝗖𝗼𝗿𝘀𝗮 𝗱𝗲𝗹𝗹𝗮 𝗦𝗽𝗲𝗿𝗮𝗻𝘇𝗮 returns to Lugano on June 15, 2025, to celebrate 20 years of solidarity and movement for cancer research. We encourage you to participate in this meaningful event, because every step counts! 👉 See lnkd.in/gpa3cH29 for details about the programme and registration.

The countdown for the IBSA Foundation Forum is on – don’t miss it on 30 June 2025! More info: www.linkedin.com/posts/ibsa-f...

#IORjobs Open PhD Position! Join Arianna Baggiolini @ariannabaggiolini.bsky.social ’s Lab to work on human pluripotent stem cell (hPSC)-based models of the peripheral nervous system and disease. Info and application: ior.usi.ch/events-news/...

#IORnews 🎉 Congratulations to Dr. Bianca Calì, research associate in our Molecular Oncology Lab, for receiving the prestigious SAKK/Astellas GU-Oncology Award 2025! ➡️ Discover more about her winning study: shorturl.at/N2UaB

#IORnews Jonas Van Lent receives the Children's Tumor Foundation's Young Investigator Award. Congrats @jonasvanlent.bsky.social ! Read more: shorturl.at/ObLS5

The IOR is glad to host the SYIS Seminar today at 5PM CET, with Arianna Calcinotto as speaker. You can still join us in person or online via Zoom (check the image below for connection details).

#IORnews IOR researchers uncover a new mechanism linking senescent cells and immune suppression in prostate cancer, paving the way for improved therapies. ➡️ Discover more: shorturl.at/7PBJ0

#IORnews 🧬 New bioinformatic tool developed at IOR: EasyCircR. This open-source R package maps circRNA-miRNA-mRNA interactions, unlocking insights into gene regulation & cancer research. Discover more: shorturl.at/xjizN

Greetings from the Institute of Oncology Research (IOR) 👋 This is our official Bluesky account — stay tuned for updates, news, and insights from the Institute. Discover more at www.ior.usi.ch